November 24, 2025 a 04:38 pm
GEHC: Analysts Ratings - GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. has seen consistent analyst interest given its comprehensive operations in medical imaging and diagnostics. While predominantly receiving positive assessments, the stability of these ratings across months indicates an optimistic yet cautious analyst sentiment. The company's innovative edge in medical diagnostics technologies continues to draw a favorable outlook.
Historical Stock Grades
The latest analyst ratings for GEHC as of November 2025 reflect a positive sentiment with a concentration on Buy and Hold recommendations. A breakdown of the latest ratings is as follows:
| Recommendation | Count | Visual |
|---|---|---|
| Strong Buy | 3 | |
| Buy | 12 | |
| Hold | 7 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
- Over the past months, GEHC has experienced stable ratings with a slight shift from Strong Buy to Buy recommendations.
- The overall volume of ratings has remained stable, signaling consistent analyst monitoring.
- Hold ratings have seen a minor upswing, indicating a moderate level of caution among analysts.
Percentage Trends
- Recent months illustrate a stable distribution, with Buy ratings dominating the sentiment landscape.
- The percentage distribution for November 2025 shows 15% Strong Buy, 60% Buy, and 25% Hold.
- The shift from Strong Buy to Hold indicates a growing moderate outlook but still reflects predominant confidence.
Latest Analyst Recommendations
Recent analyst actions for GEHC have shown a predominant trend of maintaining existing ratings, indicating stable confidence:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-11-21 | Buy | Buy | BTIG |
| 2025-10-30 | Outperform | Outperform | Evercore ISI Group |
| 2025-10-30 | Equal Weight | Equal Weight | Morgan Stanley |
| 2025-10-30 | Overweight | Overweight | Wells Fargo |
| 2025-10-13 | Buy | Buy | BTIG |
Analyst Recommendations with Change of Opinion
Changes in opinion reflect a dynamic view among analysts, with the following notable updates:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-10-07 | Neutral | Buy | Citigroup |
| 2025-05-05 | Neutral | Sell | UBS |
| 2025-03-11 | Buy | Neutral | Goldman Sachs |
| 2025-01-08 | Buy | Hold | Jefferies |
| 2024-09-26 | Sell | Neutral | UBS |
Interpretation
The analyst community's generally stable sentiment towards GEHC indicates underlying confidence in the company's strategic direction. The notable consistency in Buy and Hold recommendations suggests a robust market position with potential for growth. However, recent downshifts in opinion from some analysts imply increased market volatility or reevaluation of the company's top-line growth strategies. Analysts appear to maintain a cautiously optimistic stance, with no significant shifts foreseen in the immediate term.
Conclusion
GEHealthCare Technologies Inc. presents an enticing proposition for investors with its steady flow of Buy ratings and robust market position in healthcare technology products and solutions. While some variability in analyst sentiment is evident, the overarching confidence suggests a favorable outlook. Investors should, however, carefully monitor any shifts toward more neutral ratings that could indicate a reassessment of growth expectations or market conditions.